MobiHealthNews: "Antidote Technologies raises $11M to speed development of trial matching platform"

We're excited about what we'll be able to accomplish after our $11 million funding round led by Merck, announced this week. MobiHealthNews covered the announcement: 

"[London]-based Antidote Technologies expects it will soon be able to accelerate the development of capabilities for its trial matching platform – including precision medicine and EHR matching. That’s because the company has just entered into an agreement for an $11 million funding round led by Merck Global Health Innovation Fund, and joined by existing investors Smedvig Capital and Octopus Ventures. Regulatory clearances still need to come through, but that’s expected to happen later this year."

Read more at MobiHealthNews.